In the following studies attributes of SAS1B are defined that support its candidacy as a tumor cell-specific target antigen, including tumor cell-surface accessibility, immunogenicity, internalization of immune complexes into the endosomal-lysosomal system, and immunotoxin delivery resulting in tumor cell growth arrest in vitro. This evidence concerns the gene ASTL and neoplasm.